Oligometastatic prostate cancer: Reality or figment of imagination?

por Foster, Corey C., Weichselbaum, Ralph R., Pitroda, Sean P.
Publicado 2018

Less advanced disease at initiation of salvage androgen deprivation therapy is associated with decreased mortality following biochemical failure post-salvage radiation therapy

por Foster, Corey C, Jackson, William C, Foster, Benjamin C, Johnson, Skyler B, Feng, Felix Y, Hamstra, Daniel A
Publicado 2014

Overall survival according to immunotherapy and radiation treatment for metastatic non-small-cell lung cancer: a National Cancer Database analysis

por Foster, Corey C., Sher, David J., Rusthoven, Chad G., Verma, Vivek, Spiotto, Michael T., Weichselbaum, Ralph R., Koshy, Matthew
Publicado 2019

Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy

por Foster, Corey C., Lee, Andrew Y., Furtado, Larissa V., Hart, John, Alpert, Lindsay, Xiao, Shu-Yuan, Hyman, Neil H., Sharma, Manish R., Liauw, Stanley
Publicado 2018

Correction: Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation...

por Foster, Corey C., Lee, Andrew Y., Furtado, Larissa V., Hart, John, Alpert, Lindsay, Xiao, Shu-Yuan, Hyman, Neil H., Sharma, Manish R., Liauw, Stanley L.
Publicado 2018

A prostate-specific antigen doubling time of <6 months is prognostic for metastasis and prostate cancer-specific death for patients receiving salvage radiation therapy post radical...

por Jackson, William C, Johnson, Skyler B, Li, Darren, Foster, Corey, Foster, Benjamin, Song, Yeohan, Schipper, Matthew, Shilkrut, Mark, Sandler, Howard M, Morgan, Todd M, Palapattu, Ganesh S, Hamstra, Daniel A, Feng, Felix Y
Publicado 2013